Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones

British Journal of Haematology

Volumn 104, Issue 3, 1999, Pages 581-588

  Pepper, C ^a   Thomas, A ^a   Hoy, T ^b   Bentley, Paul ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; B cell chronic lymphocytic leukaemia; Bax; Bcl 2; Chlorambucil

Indexed keywords

CHLORAMBUCIL; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033061417     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01210.x     Document Type: Article

References (24)

1. Agular-Santelises, M., Rottenberg, M.E., Lewin, N., Mellstedt, H. & Jondal, M. (1996) Bcl-2, bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression. International Journal of Cancer, 69, 114-119.
2. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C. & Boivin, P. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198-206.
3. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. & Rai, K.R., (1996) National Cancer Institute-sponsored Working Group Guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990-4997.
4. Ferlini, C., Di Cesare, S., Rainaldi, G., Malorni, W., Samoggia, P., Biselli, R. & Fattorossi, A. (1996) Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry, 24, 106-115.
5. Gottardi, D., Alfarano, A., De Leo, A.M., Stacchini, A., Bergui, L. & Caligaris-Cappio, F. (1995) Defective apoptosis due to bcl-2 overexpression may explain why B-CLL cells accumulate in GO. Current Topics in Microbiology and Immunology, 194, 307-312.
6. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. & Reed, J.C. (1993) bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820-1828.
7. Jacobson, M.D., Burne, J.F., King, M.P., Miyashita, T., Reed, J.C. & Raff, M.C. (1993) bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature, 361, 365-368.
8. Johnston, J.B., Daeninck, P., Verburg, L., Lee, K., Williams, G., Israels, L.G., Mowat, M.R.A. & Begleiter, A. (1997) P53, mdm2, Bax and Bcl-2 and drug resistance in chronic lymphocytic leukemia. Leukemia and Lymphoma, 26, 435-440.
9. Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C.M., Rae, K., Hines, J. & Reed, J.C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood, 91, 3379-3389.
10. Knudson, C.M. & Korsmeyer, S.J. (1997) Bcl-2 and Bax function independently to regulate cell death. Nature Genetics, 16, 358-363.
11. Korsmeyer, S. (1992) bcl-2 initiales a new category of oncogenes: regulators of cell death. Blood, 80, 879-886.
12. Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E. & Oltvai, Z.N. (1993) bcl-2/bax: a rheostat that regulates an anti-oxidant pathway and cell death. Seminars in Cancer Biology, 4, 327-332.
13. McConkey, D.J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T.J., Reed, J.C. & Keating, M. (1996) Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. Journal of Immunology, 156, 2624-2630.
14. Oltvai, Z.N., Milliman, C.L. & Korsmeyer, S.J. (1993) bcl-2 heterodimerizes in vitro with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74, 609-619.
15. Panayiotidis, P., Ganeshaguru, K., Jabbar, S.A.B. & Hoffbrand, A.V. (1993) Interleukin 4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology, 85, 439-445.
16. Pepper, C., Bentley, P. & Hoy, T. (1996) Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 95, 513-517.
17. Pepper, C., Hoy, T. & Bentley, P. (1997) Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. British Journal of Cancer, 76, 935-938.
18. Reed, J.C. (1995a) bcl-2 family proteins: regulators of chemoresistance in cancer. Toxicology Letters, 82/83, 155-158.
19. Reed, J.C. (1995b) bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematology/Oncology Clinics of North America, 9, 451-473.
20. Robertson, L.E. & Plunkett, W (1993) Apoptotic cell death in chronic lymphocytic leukemia. Leukemia and Lymphoma, 11, (Suppl. 2), 71-74.
21. Robertson, L.E., Plunkett, W, McConnell, K., Keating, M.J. & McDonnell, T.J. (1996) Bcl-2 expression in chronic lymphocytic leukemia antl its correlation with the induction of apoptosis and clinical outcome. Leukemia, 10, 456-459.
22. Selvakumaran, M., Lin, H.-K., Miyashita, T., Wang, H.G., Krajewski, S., Reed, J.C., Hoffman, B. & Liebermann, D. (1994) Immediate early up-regulation of Bax expression by p53 but not TGFβ 1: a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
23. Thomas, A., El Rouby, S., Reed, J.C., Krajewski, S., Silber, R., Potmesil, M. & Newcomb, E.W. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12, 1055-1062.
24. Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. (1995) A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods, 184, 39-51.